Literature DB >> 26616294

Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells.

Letizia Mezzasoma1, Cinzia Antognelli2, Vincenzo Nicola Talesa3.   

Abstract

Atrial natriuretic peptide (ANP) is an hormone/paracrine/autocrine factor regulating cardiovascular homeostasis by guanylyl cyclase natriuretic peptide receptor (NPR-1). ANP plays an important role also in regulating inflammatory and immune systems by altering macrophages functions and cytokines secretion. Interleukin-1β (IL-1β) is a potent pro-inflammatory cytokine involved in a wide range of biological responses, including the immunological one. Unlike other cytokines, IL-1β production is rigorously controlled. Primarily, NF-kB activation is required to produce pro-IL-1β; subsequently, NALP3 inflammasome/caspase-1 activation is required to cleave pro-IL-1β into the active secreted protein. NALP3 is a molecular platform capable of sensing a large variety of signals and a major player in innate immune defense. Due to their pleiotropism, IL-1β and NALP3 dysregulation is a common feature of a wide range of diseases. Therefore, identifying molecules regulating IL-1β/NALP3/caspase-1 expression is an important step in the development of new potential therapeutic agents. The aim of our study was to evaluate the effect of ANP on IL-1β/NALP3/caspase-1 expression in LPS/ATP-stimulated human THP1 monocytes. We provided new evidence of the direct involvement of ANP/NPR-1/cGMP axis on NF-kB/NALP3/caspase-1-mediated IL-1β release and NF-kB-mediated pro-IL-1β production. In particular, ANP inhibited both NF-kB and NALP3/caspase-1 activation leading to pro- and mature IL-1β down-regulation. Our data, pointing out a modulatory role of this endogenous peptide on IL-1β release and on NF-kB/NALP3/caspase-1 activation, indicate an important anti-inflammatory and immunomodulatory effect of ANP via these mechanisms. We suggest a possible employment of ANP for the treatment of inflammatory/immune-related diseases and IL-1β/NALP3-associated disorders, affecting millions of people worldwide.

Entities:  

Keywords:  Atrial natriuretic peptide; Caspase-1; Interleukin-1β; NALP3 inflammasome; Nuclear factor-kB; THP1 cells

Mesh:

Substances:

Year:  2016        PMID: 26616294     DOI: 10.1007/s12026-015-8751-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  66 in total

1.  Differential expression of NLRP3 among hematopoietic cells.

Authors:  Greta Guarda; Manuel Zenger; Amir S Yazdi; Kate Schroder; Isabel Ferrero; Philippe Menu; Aubry Tardivel; Chantal Mattmann; Jürg Tschopp
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

2.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 3.  Endothelial actions of atrial and B-type natriuretic peptides.

Authors:  Michaela Kuhn
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  Inflammasome activation and IL-1β and IL-18 processing during infection.

Authors:  Frank L van de Veerdonk; Mihai G Netea; Charles A Dinarello; Leo A B Joosten
Journal:  Trends Immunol       Date:  2011-02-18       Impact factor: 16.687

Review 5.  AGE/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential.

Authors:  Christina Piperi; Athanasios Goumenos; Christos Adamopoulos; Athanasios G Papavassiliou
Journal:  Int J Biochem Cell Biol       Date:  2015-01-17       Impact factor: 5.085

6.  Effectiveness of human atrial natriuretic peptide supplementation in pulmonary edema patients using the pulse contour cardiac output system.

Authors:  Yuichiro Sakamoto; Kunihiro Mashiko; Nobuyuki Saito; Hisashi Matsumoto; Yoshiaki Hara; Noriyoshi Kutsukata; Hiroyuki Yokota
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

7.  ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.

Authors:  Junjie Xing; Anna A Birukova
Journal:  Microvasc Res       Date:  2009-11-26       Impact factor: 3.514

8.  Atrial natriuretic factor: a hormone produced by the heart.

Authors:  A J de Bold
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

9.  Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat.

Authors:  K Aiura; M Ueda; M Endo; M Kitajima
Journal:  Crit Care Med       Date:  1995-11       Impact factor: 7.598

Review 10.  Of inflammasomes and pathogens--sensing of microbes by the inflammasome.

Authors:  Franz Bauernfeind; Veit Hornung
Journal:  EMBO Mol Med       Date:  2013-05-13       Impact factor: 12.137

View more
  21 in total

1.  Inflammation and Circulating Natriuretic Peptide Levels.

Authors:  Hannah Fish-Trotter; Jane F Ferguson; Nirav Patel; Pankaj Arora; Norrina B Allen; Katherine N Bachmann; Lori B Daniels; Muredach P Reilly; Joao A C Lima; Thomas J Wang; Deepak K Gupta
Journal:  Circ Heart Fail       Date:  2020-06-08       Impact factor: 8.790

2.  IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma.

Authors:  Wei Chen; Mingjuan Hu; Tao Wei; Ying Liu; Tian Tan; Chengfang Zhang; Jiaxuan Weng
Journal:  J Gastrointest Oncol       Date:  2022-06

3.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

Review 4.  The Roles of Inflammasomes in Host Defense against Mycobacterium tuberculosis.

Authors:  Jialu Ma; Shasha Zhao; Xiao Gao; Rui Wang; Juan Liu; Xiangmei Zhou; Yang Zhou
Journal:  Pathogens       Date:  2021-01-25

5.  A Novel Role for Brain Natriuretic Peptide: Inhibition of IL-1β Secretion via Downregulation of NF-kB/Erk 1/2 and NALP3/ASC/Caspase-1 Activation in Human THP-1 Monocyte.

Authors:  Letizia Mezzasoma; Cinzia Antognelli; Vincenzo Nicola Talesa
Journal:  Mediators Inflamm       Date:  2017-02-26       Impact factor: 4.711

6.  Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion.

Authors:  Su-Chen Ho; Yi-Huang Chang
Journal:  Molecules       Date:  2018-02-21       Impact factor: 4.411

7.  LCZ696 mitigates diabetic-induced nephropathy through inhibiting oxidative stress, NF-κB mediated inflammation and glomerulosclerosis in rats.

Authors:  Mohamed Mohany; Ahmed Z Alanazi; Faleh Alqahtani; Osamah M Belali; Mohammed M Ahmed; Salim S Al-Rejaie
Journal:  PeerJ       Date:  2020-06-19       Impact factor: 2.984

8.  Natriuretic Peptides Regulate Prostate Cells Inflammatory Behavior: Potential Novel Anticancer Agents for Prostate Cancer.

Authors:  Letizia Mezzasoma; Vincenzo Nicola Talesa; Egidia Costanzi; Ilaria Bellezza
Journal:  Biomolecules       Date:  2021-05-25

9.  Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.

Authors:  Takuya Wakamatsu; Suguru Yamamoto; Toru Ito; Yoko Sato; Koji Matsuo; Yoshimitsu Takahashi; Yoshikatsu Kaneko; Shin Goto; Junichiro James Kazama; Fumitake Gejyo; Ichiei Narita
Journal:  Toxins (Basel)       Date:  2018-03-15       Impact factor: 4.546

Review 10.  Natriuretic Peptides: The Case of Prostate Cancer.

Authors:  Letizia Mezzasoma; Matthew J Peirce; Alba Minelli; Ilaria Bellezza
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.